June 24, 2021 – The U.S. FDA has granted emergency use authorization (EUA) to Actemra® (tocilizumab – Genentech) to treat COVID-19 in hospitalized patients who are at least
June 17, 2021 – The U.S. FDA has approved Astepro® Allergy (azelastine hydrochloride nasal spray, 0.15%), manufactured by Bayer, for over-the-counter (OTC) use to provide temporary
June 16, 2021 – Smiths Medical has recalled multiple lots of Jelco® Hypodermic Needle-Pro® Fixed Needle Insulin Syringes that may have skewed gradation markings on the syringe barrels
June 16, 2021 – The U.S. FDA has approved a new indication for AyvakitTM (avapritinib), manufactured by Blueprint Medicines. The drug is now indicated to treat adults who have
June 15, 2021 – The U.S. FDA has approved Rezipres® (ephedrine hydrochloride injection), manufactured by Eton Pharmaceuticals, to treat clinically important hypotension occurring